Certified ISO 9001:2015 and located near Montpellier, France, over 140 employees work in our modern, 4000 m² facilities where all our activities take place: Research and Development, Innovation, Production, Sales and Marketing.

Research & Development

Our R&D activities ensure that our products reflect the cutting-edge of RT-PCR and ELISA technology, and allow us to continuously launch new, innovative tests.

To remain at the forefront of infectious disease diagnostics, we re-invest 30% of our turnover in R&D projects, work closely with leading scientists and reference laboratories worldwide, and participate in European research programs.

Industrial know-how

All kit components are produced on-site to guarantee reagent quality and availability.
Our tests are developed and produced to meet the highest criteria of stability and standardization.

Thanks to our highly automatized production line, we are equipped for high throughput production. Up to 2000 ELISA plates can be produced per day.

Our exceptional customer service and global presence: “With you at every step”

Thanks to our vast distribution network, our products are today used in over 140 countries, and we have offices in Brazil, India and China, and a production facility in the United States.

We are committed to providing our clients with the best technical support and provide training in the application of our tests and the interpretation of results. We furthermore advise on laboratory design to provide our clients with the best foundations.

With a dynamic R&D department, high quality products, a diverse product portfolio and excellent customer service, Innovative Diagnostics has become a leader in the domain of veterinary and zoonotic disease diagnosis.

Innovative Diagnostics Downloads

DI SARS-COV-2 IRES DUPLEX (CE-IVD) - Sheet

DI SARS-COV-2 REST DUPLEX (CE-IVD) - Sheet